The Enterprise Value as of December 2025 (TTM) for CARsgen Therapeutics Holdings Limited (2171.HK) is 6.34B

According to CARsgen Therapeutics Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 6.34B. This represents a change of 430.72% compared to the average of 1.20B of the last 4 quarters.

CARsgen Therapeutics Holdings Limited (2171.HK) Historical Enterprise Value (quarterly & annually)

How has 2171.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of CARsgen Therapeutics Holdings Limited over the last ten years is 4.59B. The current 6.34B Enterprise Value has changed 13.72% with respect to the historical average. Over the past ten years (40 quarters), 2171.HK's Enterprise Value was at its highest in in the December 2021 quarter at 11.97B. The Enterprise Value was at its lowest in in the June 2025 quarter at -1119938000.00.

CARsgen Therapeutics Holdings Limited (2171.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CARsgen Therapeutics Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CARsgen Therapeutics Holdings Limited (2171.HK) Average Enterprise Value

How has 2171.HK Enterprise Value performed in the past?

The current Enterprise Value of CARsgen Therapeutics Holdings Limited (2171.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CARsgen Therapeutics Holdings Limited (2171.HK) Enterprise Value vs. Peers

How is 2171.HK’s Enterprise Value compared to its peers?

CARsgen Therapeutics Holdings Limited’s Enterprise Value is less than CStone Pharmaceuticals (7.59B), less than Ascletis Pharma Inc. (10.03B), less than Abbisko Cayman Limited (7.30B), less than CK Life Sciences Int'l., (Holdings) Inc. (13.78B), greater than HBM Holdings Limited (1.00B), less than Nanjing Leads Biolabs Co Ltd (0), less than Alphamab Oncology (8.48B), less than Lepu Biopharma Co., Ltd. (9.48B), greater than Ocumension Therapeutics (5.59B), less than Brainaurora-b (6.65B),

Build a custom stock screener for CARsgen Therapeutics Holdings Limited (2171.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CARsgen Therapeutics Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CARsgen Therapeutics Holdings Limited (2171.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CARsgen Therapeutics Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.